Celebrating Kazakhstan Republic Day

Coagulation, Thrombosis, Hemostasis

Celebrate Republic Day on October 25, 2025, and pay tribute to the glorious beginning of Kazakhstan's sovereignty and independence!
Beijing Succeeder Technology Inc. extends its sincerest wishes!

Beijing Succeeder Technology Inc. (stock code: 688338) has been deeply engaged in the field of coagulation diagnosis since its establishment in 2003, and is committed to becoming a leader in this field. Headquartered in Beijing, the company has a strong R&D, production and sales team, focusing on the innovation and application of thrombosis and hemostasis diagnostic technology.

With its outstanding technical strength, Succeeder has won 45 authorized patents, including 14 invention patents, 16 utility model patents and 15 design patents. The company also has 32 Class II medical device product registration certificates, 3 Class I filing certificates, and EU CE certification for 14 products, and has passed ISO 13485 quality management system certification to ensure the excellence and stability of product quality.

Succeeder is not only a key enterprise of the Beijing Biomedicine Industry Leapfrog Development Project (G20), but also successfully landed on the Science and Technology Innovation Board in 2020, achieving leapfrog development of the company. At present, the company has built a nationwide sales network covering hundreds of agents and offices. Its products are sold well in most parts of the country. It is also actively expanding overseas markets and continuously improving its international competitiveness.